High yield expression of catalytically active USP18 (UBP43) using a Trigger Factor fusion system

Anja Basters1, Lars Ketscher, Elke Deuerling

  • 1Department of Neuropathology, University of Freiburg, Freiburg, Germany.

BMC Biotechnology
|August 25, 2012
PubMed
Summary

A novel chaperone fusion system enables high-level expression of USP18, a key protease targeting ISG15. This facilitates the development of new antiviral therapies by enabling inhibitor screens against viral replication.